2024
2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache.
Sico J, Antonovich N, Ballard-Hernandez J, Buelt A, Grinberg A, Macedo F, Pace I, Reston J, Sall J, Sandbrink F, Skop K, Stark T, Vogsland R, Wayman L, Ford A. 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache. Annals Of Internal Medicine 2024, 177: 1675-1694. PMID: 39467289, DOI: 10.7326/annals-24-00551.Peer-Reviewed Original ResearchClinical practice guidelinesU.S. Department of Veterans AffairsTension-type headacheDepartment of Veterans AffairsVeterans AffairsManagement of headacheCalcitonin gene-related peptidePractice guidelinesEpisodic migraineDefense Clinical Practice GuidelinesPrimary care cliniciansManagement of tension-type headacheRevised CPGTreatment of tension-type headacheDepartment of Defense Clinical Practice GuidelinesChronic tension-type headacheCalcitonin gene-related peptide monoclonal antibodiesTreatment of acute migrainePrevention of chronic migraineAerobic exerciseCare cliniciansPreventing episodic migrainePhysical therapyNonpharmacological interventionsSecondary headache disorders
2022
Measuring interictal burden among people affected by migraine: a descriptive survey study
Hubig L, Smith T, Williams E, Powell L, Johnston K, Harris L, L’Italien G, Coric V, Lloyd A, Lo S. Measuring interictal burden among people affected by migraine: a descriptive survey study. The Journal Of Headache And Pain 2022, 23: 97. PMID: 35941572, PMCID: PMC9358846, DOI: 10.1186/s10194-022-01467-z.Peer-Reviewed Original ResearchConceptsMonthly migraine daysMonthly headache daysInterictal burdenMAb treatmentHIT-6Calcitonin gene-related peptide monoclonal antibodiesMean HIT-6 scoreOverall disease burdenHealth-related qualityIndependent positive associationHeadache Impact TestHIT-6 scoresImpact of migrainePeptide monoclonal antibodyMigraine-free daysPositive associationCross-sectional online surveyMigraine daysPatient characteristicsPatient demographicsMigraine frequencyHeadache daysMigraine attacksMigraine episodesBurden Scale
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply